Sort
326,823 grants matching “clinical trial”
Northwestern Cancer Prevention Consortium
$1,974,998Seema Ahsan Khan · Northwestern University At Chicago · UG1 · FY2021 · CA
Comprehensive Cancer Center of Wake Forest University CCOP Research Base
$1,974,959Edward G Shaw · Wake Forest University Health Sciences · U10 · FY2010 · CA
Data Coordination Center for PDX Net
$1,974,874Jeffrey Hsu-Min Chuang · Jackson Laboratory · U24 · FY2017 · CA
Melanoma and Skin Cancer Program SPORE
$1,974,834Hassane M Zarour · University Of Pittsburgh At Pittsburgh · P50 · FY2023 · CA
Transition from Risk Factors to Early HF: Prevalence, Pathogenesis, and Phenomics
$1,974,550Alain Gerald Bertoni · Wake Forest University Health Sciences · R01 · FY2015 · HL
HIV/AIDS Clinical Trials Units University of Cape Town CTU 2020 to 2027
$1,974,550Linda-Gail Bekker · University Of Cape Town · UM1 · FY2023 · AI
Host-Tumor Cell Interactions in Myeloma:
$1,974,474Dana-Farber Cancer Institute · P01 · FY2004 · CA
Host-tumor cell interaction in myeloma: therapeutic applications
$1,974,463Kenneth C Anderson · Dana-Farber Cancer Inst · P01 · FY2012 · CA
NIDA Clinical Trials Network: Greater New York Node
$1,974,434John P Rotrosen · New York University School Of Medicine · UG1 · FY2019 · DA
Center for Prevention and Early Intervention
$1,974,395Nicholas S Ialongo · Johns Hopkins University · P30 · FY2009 · MH
Molecular Imaging and Its Response to Therapy
$1,974,384Kenneth A. Krohn · University Of Washington · P01 · FY2007 · CA
Translational Research in Breast Cancer
$1,974,356Xiang Zhang · Baylor College Of Medicine · P50 · FY2023 · CA
HIV Vaccine Design and Development Team
$1,974,283Progenics Pharmaceuticals, Inc. · R01 · FY2000 · AI
A Phase 2b Clinical Trial to Study the Efficacy of Longeveron Mesenchymal Stem Cells (LMSCs) to Treat Aging Frailty
$1,974,282Anthony Andrew Oliva · Longeveron, Llc · R44 · FY2020 · AG
Vaccination against mucosal HIV clade C transmission
$1,974,218Ruth Margrit Ruprecht · Dana-Farber Cancer Inst · P01 · FY2009 · AI
Preserving Renal Function & Protective Immunity Via Anti-LFA1-Based CNI Avoidance
$1,974,106Kenneth A Newell · Emory University · U01 · FY2012 · AI
The regulation of health and longevity by branched-chain amino acids
$1,973,962Dudley William Lamming · University Of Wisconsin-Madison · RF1 · FY2023 · AG
Antiretroviral Treatment Interruption as a Long-term Therapeutic Strategy
$1,973,961Steven Reynolds · Niaid Extramural Activities · Z01 · FY2007 · AI
Eradicating stereotype threat: intervening to retain and advance women faculty
$1,973,881Hannah Augusta Valantine · Stanford University · DP4 · FY2010 · GM
Cancer Immune Monitoring and Analysis Center
$1,973,873Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · U24 · FY2023 · CA
Prenatal Environment And Child Health (PEACH) in ECHO
$1,973,808Rebecca Jean Schmidt · University Of California At Davis · UH3 · FY2025 · OD
MOTOR-Maternal Oral Therapy to Reduce Obstetric Risk
$1,973,572Steven Nmn Offenbacher · Univ Of North Carolina Chapel Hill · U01 · FY2007 · DE
PumpKIN PreClinical
$1,973,534Mark Gartner · Ension, Inc. · N01 · FY2012 · HL
MOLECULAR BIOMARKERS FOR ENVIRONMENTAL CARCINOGENS
$1,973,433Johns Hopkins University · P01 · FY2002 · ES
Therapeutics for inflammatory bowel disease from the microbiome
$1,973,386Sarkis K Mazmanian · Symbiotix Biotherapies, Inc. · R42 · FY2016 · DK